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This study explores the dilemma in cellular signaling that triggering of CD95 (Fas/APO-1) in some
situations results in cell death and in others leads to the activation of NF-jB. We established an
integrated kinetic mathematical model for CD95-mediated apoptotic and NF-jB signaling.
Systematic model reduction resulted in a surprisingly simple model well approximating
experimentally observed dynamics. The model postulates a new link between c-FLIPL cleavage in
the death-inducing signaling complex (DISC) and the NF-jB pathway. We validated experimentally
that CD95 stimulation resulted in an interaction of p43-FLIP with the IKK complex followed by its
activation. Furthermore, we showed that the apoptotic and NF-jB pathways diverge already at the
DISC. Model and experimental analysis of DISC formation showed that a subtle balance of c-FLIPL
and procaspase-8 determines life/death decisions in a nonlinear manner. We present an integrated
model describing the complex dynamics of CD95-mediated apoptosis and NF-jB signaling.
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Introduction
The CD95 protein (APO-1/Fas; Krammer et al, 2007) is a
member of the death receptor (DR) family, a subfamily of
the tumor necrosis factor receptor (TNF-R) superfamily
(Ashkenazi and Dixit, 1998; Krammer, 2000). Cross linking
of CD95 with its natural ligand, CD95L, or with agonistic anti-
CD95 antibodies induces apoptosis in sensitive cells (Trauth
et al, 1989). The signal transduction of CD95 starts with the
formation of the death-inducing signaling complex (DISC)
detectable within seconds after receptor stimulation (Kischkel
et al, 1995). The DISC consists of CD95, the adaptor molecule
FADD, procaspase-8a/b, procaspase-10 and c-FLIPL/S/R
(Muzio et al, 1996; Scafﬁdi et al, 1999; Sprick et al, 2002;
Golks et al, 2005; Krammer et al, 2007). Procaspase-8 is
converted at the DISC, through a series of autoproteolytic
cleavage steps, into p43/p41 and p18, which leads to the
activation of effector caspase-3 (Lavrik et al, 2003). This can
occur in two different ways in type I and type II cells (Scafﬁdi
et al, 1998). Type I cells are characterized by high levels of
CD95 DISC formation and increased amounts of active
caspase-8, leading to the direct activation of downstream
effector caspases-3 and -7 and subsequent apoptosis. Type II
cellsarecharacterizedbylowerlevelsofCD95DISCformation,
and caspase-3 activation requires additional ampliﬁcation
throughthereleaseofpro-apoptoticfactorsfrommitochondria
triggered by the caspase-8-mediated cleavage of the Bcl-2
family protein Bid.
Recently, experiments have demonstrated that CD95L is not
only a potent apoptosis inducer but can also activate multiple
nonapoptotic pathways, in particular induction of transcrip-
tion factor NF-kB (Barnhart et al, 2004; Kreuz et al, 2004; Peter
et al, 2007). The NF-kB family regulates the expression of
genes crucial for innate and adaptive immune responses, cell
growth and apoptosis. In most cells, the NF-kB dimer is
sequesteredinthecytosolbyinhibitorsofthekBprotein(IkB),
and its nuclear translocation can be induced by a wide
variety of stimuli through activation of the IkB kinase (IKK)
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The IKK complex consists of two catalytic subunits, IKKa and
IKKb, and a regulatory subunit IKKg/NEMO. On activation
of the IKK complex, IkB is phosphorylated and degraded
inanubiquitin-dependentmanner.TheNF-kBdimerscanthen
translocate into the nucleus to induce transcription of
target genes. However, the exact molecular mechanism
of NF-kB activation through CD95 remains unclear (Peter
et al, 2007).
It has been previously shown that DED-containing
proteins, such as procaspase-8 and c-FLIP have a prominent
roleinNF-kBactivation(Chaudharyetal,2000;Huetal,2000;
Kreuz et al, 2004; Dohrman et al, 2005; Su et al, 2005). c-FLIP
N-terminal cleavage products p43-FLIP and p22-FLIP strongly
induce NF-kB (Kataoka and Tschopp, 2004; Golks et al,
2006a). p43-FLIP is generated by procaspase-8 at the
DISC on CD95 stimulation (Scafﬁdi et al, 1999; Krueger et al,
2001). It has been shown to interact with components
of the TNFR-mediated NF-kB activation pathway, TNFR-
associated factor 1 (TRAF1), TRAF2 and receptor-interacting
protein (RIP), which together promote NF-kB activation
(Kataoka and Tschopp, 2004; Dohrman et al, 2005). Interest-
ingly, it has been shown that c-FLIPL/S/R form heterodimers
with procaspase-8, resulting in the generation of the
cleavage fragment p22-FLIP (Golks et al, 2006a). This protein
mediates NF-kB activation by binding directly to the IKK
complex. p22-FLIP differs from p43-FLIP in that it is generated
in nonapoptotic cells without DR stimulation (Golks et al,
2006a). Furthermore, it was also reported that the binding
of procaspase-8 in the MALT1–Bcl-10 adapter complex formed
on TCR stimulation has a prominent role in NF-kB induction
(Su et al, 2005). Thus, various molecules of the CD95
signaling machinery, such as procaspase-8 and c-FLIP have a
complex role in CD95-mediated apoptosis and NF-kB
pathways. These ﬁndings motivated our systems biology
approach and prompted us to determine whether CD95-
mediated signaling should be considered as a dynamic system
resulting in life/death decisions. It has been shown repeatedly
that decision making is often a process brought about by a
reaction system rather than by the inﬂuence of a single
molecule (Xiong and Ferrell, 2003; Legewie et al, 2006; Santos
et al, 2007).
Modeling in biology has a long tradition and can be dated
back to Hodgkin and Huxley’s model of a neuron (Hodgkin
and Huxley, 1952). Awide gamut of modeling formalisms has
been applied to biological systems ranging from qualitative
approaches, such as Boolean and Bayesian networks (Sun and
Zhao, 2004) to partial differential equations and stochastic
simulations. A number of models typically based on ordinary
differential equations (ODEs) have described apoptosis
signaling. Fussenegger et al (2000) presented the ﬁrst
mathematical model encompassing both extrinsic and intrin-
sic apoptotic pathways. A more detailed model with para-
meters estimated from quantitative western blots veriﬁed a
threshold for CD95 stimulation regulated by c-FLIP (Bentele
et al, 2004). Advanced models of apoptosis have been used to
discriminate between different hypotheses of apoptosis
inhibition by Bcl-2 family members and XIAPs (Hua et al,
2005; Rehm et al, 2006). Others have addressed aspects, such
as feedback and bistability (Eissing et al, 2004; Janes et al,
2005; Bagci et al, 2006; Legewie et al, 2006). A number of
mathematical models for NF-kB activation have investigated
the complex interplay of various IkB subunits in NF-kB
oscillatory activity (Hoffmann et al, 2002; Nelson et al, 2004;
Cheong et al, 2008). Furthermore, the signaling of the TNF
pathway leading to NF-kB activation was modeled (Cheong
et al, 2006; Park et al, 2006).
Despite much study on both apoptotic and NF-kB signaling
pathways induced by CD95, there is a lack of a detailed
mechanistic understanding of the divergence of these path-
ways. In the following text, we propose an integrated
quantitative model supported by experimental data for
CD95-mediated apoptosis and NF-kB activation. A direct
interaction between p43-FLIP and the IKK complex is
postulated by the model and validated experimentally. The
model also predicts a divergence of the two pathways at the
DISC and that the cellular decision depends on the balance
between the levels of c-FLIPL and caspase-8. Experimental
modulations of DISC protein amounts are all consistent with
the model predictions. Our model gives mechanistic insights
into the cellular response on CD95 activation and provides a
way to predict cellular behavior.
Results
NF-jB and caspases show parallel activation
The CD95 protein is known to mediate the activation of
caspases leading to apoptosis (Lavrik et al, 2005) and
mediating the activation of NF-kB (Barnhart et al, 2004).
However, it is not understood whether CD95 activates
apoptotic and NF-kB pathways in a mutually exclusive
manner, or whether the activation of both pathways takes
place in parallel. To answer this question, we investigated
CD95 signaling by western blot analysis of HeLa cells stably
overexpressing CD95–GFP (HeLa-CD95) and treated the cells
with agonistic anti-CD95 antibodies at three concentrations:
1500, 500 and 250ng/ml (Figure 1A–C). Procaspase-8a/b was
processed to p43/p41 and subsequently to p18. Procaspase-3
was also cleaved to the active subunit p17 showing the
induction of the apoptotic pathway. In parallel, we observed
the phosphorylation of IkBa followed by its degradation.
Stimulation of CD95 caused apoptosis at all antibody
concentrations (Supplementary Figure S1). The quantiﬁed
blots demonstrate that apoptotic and NF-kB pathways were
activated on a similar time scale (Figure 2A–G). Interestingly,
IkBaphosphorylationwasatits maximum(Figure2F) roughly
three times faster than active caspases (Figure 2B, D and G)
at all antibody concentrations. Using live-cell images of
HeLa-CD95 cells stably overexpressing p65–mCherry, we
observed simultaneous apoptosis and nuclear translocation
of p65–mCherry in each cell on induction of CD95 (Figure 1D).
Thus, we could exclude the possibility that a subset of
cells activated NF-kB, whereas another subset activated
caspases. This demonstrates a parallel rather than a mutually
exclusive activation of caspases and NF-kB. The simultaneous
inductionofapoptosisandNF-kBactivation andtheirdifferent
dynamics led us to investigate the divergence point of the two
pathways.
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between p43-FLIP and the IKK complex is
consistent with experimental observations
To understand the crosstalk between CD95-mediated apop-
tosis and NF-kB activation, we created a mathematical model
of CD95 signaling. When we integrated known molecular
interactions into a detailed model, wefaced the problem that it
is mechanistically not understood how signals from CD95 are
transmitted to NF-kB. Taking into account earlier ﬁndings that
the c-FLIPL cleavage products, p43-FLIP and p22-FLIP, are
involved in NF-kB signaling (Kataoka and Tschopp, 2004;
Golks et al, 2006a), and that p22-FLIP is not formed upon
CD95 stimulation (Golks et al, 2006a), we hypothesized that
p43-FLIP is the missing link between the DISC and the IKK
complex. The kinetics of phosphorylated IkBa in Figure 2F
indicate a temporal correlation between CD95 stimulation and
IKK activity. The simplest scheme to explain this phenomenon
would be through p43-FLIP generation at the DISC and
subsequent interaction with the IKK complex. This led us to
the mathematical model of CD95-mediated caspase and NF-kB
activation shown in Figure 3.
Our model assumes a trimerized ligand (L) that binds to a
trimerized CD95 receptor (R) that can recruit three copies of
FADD (F) leading to the DISC formation. Subsequently, DED-
containing proteins, such as procaspase-8 (C8), c-FLIPL (FL)
and c-FLIPS (FS) can bind to FADD. The order of protein
binding gives rise to a combinatorial variety of intermediates.
A
B
C
D
Figure 1 NF-kB and caspases show parallel activation. (A–C) HeLa-CD95 cells were stimulated with (A)1500ng/ml, (B) 500ng/ml and (C) 250ng/ml of agonistic
anti-CD95 antibodies for the indicated periods of time. The cellular lysates were analyzed by western blotting using antibodies against caspases, IkBa and p-IkBa.
Nonspeciﬁc bands of anti-p-IkBa are marked (NS). Results are representative of four different experiments. (D) To follow p65 localization, Hela-CD95 cells were stably
transfected with p65–mCherry. Cells were stimulated with 1500ng/ml anti-CD95 antibody and imaged using ﬂuorescent microscopy over the respective time.
Measurements of mCherry (depicted in gray) indicated translocation of p65 on CD95 activation. Induced apoptosis is observed by the appearance of apoptotic bodies.
Scale bar: 10mm.
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ﬁrst group contains at least two copies of procaspase-8 and is
further processed by p43/p41 into active protease subunits,
p18 and p10, forming an active caspase-8 heterotetramer
(C8*). This apoptotic branch of the model also includes
procaspase-3 and procaspase-6 (C3 and C6), their active forms
(C3* and C6*), the inhibitor IAP and a feedback loop from
caspase-6 to caspase-8.
The second group of DISCs features at least one copy of
procaspase-8 and one copy of c-FLIPL giving rise to p43-FLIP.
The model postulates that p43-FLIP interacts with the IKK
complex leading to phosphorylation of IkB (NF-kB IkB P),
which entails its degradation and the translocation of p65 to
thenucleus(NF-kB*).Forsimplicity,weassumethattheentire
pool of IkB is bound to NF-kB. In the third group of DISCs, we
considered all remaining conﬁgurations. They do not partici-
pate in further signaling and are merged in a terminal state
(L R F F F X X X). The key features of the model are its
partitioning into DISC formation, apoptotic and NF-kB
signaling, and the conﬁnement of all interactions between
the two pathways to the DISC. In this model, the gene
transcription induced by NF-kB was neglected, as we aimed to
investigate early signaling events immediately after the
stimulation of CD95.
For model simulations, the molecular interactions depicted
in Figure 3 were translated into a system of coupled ODEs (for
Figure 2 Quantiﬁed response to anti-CD95 stimulation. Each of the panels (A–G) shows a quantiﬁcation of western blots shown in Figure 1A–C. The symbols mark
theaveragevalueandthe linesshowtheir linearinterpolations. Thes.d.wasincludedwhenmore thanonevalue wasobtained. Black,blue andred colorscorrespond to
1500, 500 and 250ng/ml anti-CD95 antibodies, respectively, used to induce the cells at time t¼0.
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tary Tables S1 and S2). To reduce the large number of free
parameters, we simpliﬁed the reactions to be irreversible as
previously described with the exception of a reversible
enzymatic scheme used for caspase activation (Bentele et al,
2004). The model contains unknown reaction constants and
concentrationsthatweestimatedfromourdatabyleast-squares
optimization. Remarkably, the model was able to reproduce the
experimental data set (Supplementary Figure S2) despite the
almost exclusive use of an irreversible reaction scheme.
Interestingly, it shows that the activity of effector caspases is
not required for reproducing the dynamics of CD95-mediated
NF-kB activation. In addition, the model postulates a direct
interaction between p43-FLIP and the IKK complex.
Figure 3 Model of CD95-mediated signaling. A graphic representation of the complete model illustrating the process of DISC formation and subsequent signaling of
the apoptotic (depicted in red) and NF-kB pathway (depicted in green). Abbreviations: L, CD95 ligand; R, CD95 receptor; F, FADD; C8, procaspase-8 (p55/p53); C8*,
activecaspase-8; C3, procaspase-3; C3*,active caspase-3; C6, procaspase-6; C6*,active caspase-6; FL,c-FLIPL; FS,c-FLIPS;X, C8,FL or FS; p43/p41, 1st cleavage
product of procaspase-8; and p43-FLIP, cleavage product of c-FLIPL.
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CD95 stimulation
To test our model hypothesis that p43-FLIP interacts with the
IKK complex, we transiently co-transfected p43-FLIP with
FLAG-tagged IKKa, IKKb and IKKg into 293T cells, and then
performed an immunoprecipitation (IP) using anti-FLAG
(FLAG-IP) and anti-FLIP antibodies (FLIP-IP; Figure 4A). We
observedIKKaintheFLIP-IPandp43-FLIPmostlyintheFLAG-
IKKa-IP. Thus, we established that p43-FLIP can interact with
IKKa. Next, we tested whether this interaction also occurs
under endogenous conditions on CD95 stimulation in Hela-
CD95 cells. An IP of the IKK complex using anti-IKKg
antibodies showed a recruitment of p43-FLIP to the IKK
complexat30minafterthestimulationofCD95(Figure4B).To
avoid co-IP of the CD95 DISC with the IKK complex, we used
LZ-CD95L and not anti-CD95 antibodies for stimulation in this
experiment. The RIP protein, invoked in CD95-mediated NF-
kB activation (Kreuz et al, 2004), was not detectable at the IKK
complexunderourexperimentalconditions.IntheIKKg-IP,we
also detected a band corresponding to the size of c-FLIPL,
however, the band was also detected in the isotype control IP
and,hence,isconsideredunspeciﬁc.InaCD95DISC-IP(CD95-
IP), we could not detect IKK-a/b, suggesting that the IKK
complex is not associated to the DISC (Supplementary Figure
S3). Positive controls for the CD95 DISC-IP showed that the
DISC was formed efﬁciently, for example, procaspase-8 and its
cleavage product p43/p41 were present at the DISC.
To test whether c-FLIPL or its cleavage product p43-FLIPcan
induce NF-kB, we performed NF-kB luciferase assays (Figure
4C–E). c-FLIPL and p43-FLIP were overexpressed in 293Tcells,
whichwasfollowedbyaluciferase-basedNF-kBactivityassay.
Noticeably, we found that p43-FLIP is a strong inducer of
NF-kB activity, whereas c-FLIPL exhibited low induction
efﬁciency compared with MEKK1 used as a positive control
(Figure4C).Inaddition,HeLa-CD95cellstransfectedwithp43-
FLIP showed an induction of NF-kB similar to the one
observed after TNF induction (Figure 4D). To conﬁrm that
p43-FLIP, not c-FLIPL, for example, in the absence of CD95
activation mediates NF-kB activation, we generated a mutant
form of c-FLIPL, which cannot be cleaved to p43-FLIP due to a
substitution at D376 (c-FLIPL (D376E)). To avoid unspeciﬁc
effects by the cleavage of c-FLIPL to p22-FLIP, constructs of
c-FLIP were mutated in the p22 cleavage site (D196E). c-FLIPL,
c-FLIPL (D376E) or an empty pcDNA3 vector, as a control,
wasQ2 transfected into HeLa-CD95 cells along with a NF-kB
reporter construct and a Renilla reporter construct for normal-
ization. HeLa-CD95 cells transfected with c-FLIPL (D376E)
showed decreased CD95-induced NF-kB activation, as com-
pared with HeLa-CD95 cells transfected with WT c-FLIPL
(Figure 4E). Taken together, these data conﬁrm our model
postulation that cleavage of c-FLIPL to p43-FLIP is required for
the CD95-mediated NF-kB activation through interaction of
p43-FLIP with the IKK complex.
Apoptotic and NF-jB signalings diverge
at the DISC
When establishing the model structure, we encountered the
problem in deciding whether the reported cleavage of NF-kB
pathway members by active caspase also has a role in our
experiments (Fischer et al, 2003). We decided to omit these
interactions as long as the model was in agreement with our
experimental observations. As a consequence, our model
postulates that the apoptotic and NF-kB pathways diverge
already at the DISC. During model ﬁtting, we found that this
was sufﬁcient to reproduce the dynamics of IkB phosphoryla-
tion and degradation. To test our model hypothesis, we
blocked the apoptotic pathway with the pan-caspase inhibitor,
zVAD-fmk, and investigated CD95 signaling. It was shown
previously that zVAD-fmk blocks caspase activation down-
stream from the DISC, but does not affect the processing of
procaspase-8 to the catalytically active subunit p43/p41 at the
DISC, which mediates the processing of c-FLIP to p43-FLIP
(Golks et al, 2006b; Hughes et al, 2009). The inhibitor may
bind caspase-8 only after the so-called substrate switch that is
necessary for caspase-3 and Bid cleavage but not for p43/p41
and p43-FLIP formation (Hughes et al, 2009). Therefore,
application of zVAD-fmk provides a unique experimental tool
that allows to switch off the apoptotic signaling of CD95 and
followonly thenonapoptotic events mediated byp43-FLIP. We
stimulated HeLa-CD95 cells, pre-treated with zVAD-fmk, with
anti-CD95 and analyzed NF-kB activation and cell death
signaling (Supplementary Figure S4). Using live-cell imaging
of HeLa-CD95 cells stably overexpressing p65–mCherry, we
observed nuclear translocation of p65–mCherry on induction
of CD95 (Supplementary Figure S4A). Apoptosis, however,
was not detected. Thus, we conﬁrmed that pre-treatment with
zVAD-fmk blocks CD95-induced apoptosis but does not inhibit
NF-kB activation. Western blot analysis showsthat cleavageof
c-FLIPL to p43-FLIP and phosphorylation of IkB were affected
only slightly by zVAD-fmk (Supplementary Figure S4B). Thus,
we could validate the model prediction that processed
caspases are not required for NF-kB activation and that the
apoptotic and NF-kB pathways diverge already at the DISC.
These ﬁndings underline the important role of the DISC in
distributing signals between caspases and NF-kBQ3.
Reduced model is sufﬁcient to explain dynamics
of life/death signaling
ThemodelofCD95-mediatedsignalingdepictedinFigure3isa
comprehensive integration of data for CD95 signaling path-
ways. However, its complexity might hide key features of the
mechanism of pathway divergence. Furthermore, an overly
complex model is prone to overﬁtting. To simplify the model
withoutcompromisingitspredictivepower,wetestedwhichof
the proteins and reactions of the complete model are required
to reproduce the observed dynamics. A clear advantage of a
smaller model is that it yields much more reliable parameter
estimates. To determine the most important interactions, we
simpliﬁed the complete model in a step-wise manner,
obtaining a model of considerably lower complexity
(Figure 5A). The simpliﬁcation steps are listed in Figure 5B
and the corresponding intermediate models can be found
in the Supplementary information (Supplementary Figure
S5A–G). We repeated the parameter estimation after each step
of model reduction. The ﬁt of the complete model was set to
100% and the performance of the reduced models was
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number of reduction steps the goodness of ﬁt decreased only
slightly. Further model reduction led to a marked decrease in
model ﬁt (data not shown); hence we decided to consider
model 8 as the ﬁnal reduced model. This reduced model 8
(Figure 5A, Supplementary Figure S5G) still approximated
well with the experimental data set (Figure 5D), however, it
should be noted that a permutation of the simpliﬁcation steps
Be Be
A
B
CD E
Figure 4 p43-FLIP interacts with the IKK complex on CD95 stimulation. (A) The association of p43-FLIP with components of the IKK complex was determined using
co-immunoprecipitations (IPs). 293T cells were co-transfected with FLAG-tagged IKKa, IKKb or IKKg with or without p43-FLIP. The lysates were immunoprecipitated
using antibodies against the FLAG tag or against c-FLIP and analyzed by western blotting using antibodies against the FLAG tag or c-FLIP (left side). In parallel,
corresponding lysates were also analyzed using western blot analysis with the same antibodies as the immunoprecipitation (right side). (B) The association of p43-FLIP
with the IKK complex under endogenous conditions was determined using co-immunoprecipitations of IKKg (IKKg-IP). HeLa-CD95 cells were stimulated with 500ng/ml
of LZ-CD95L for the indicated time intervals and immunoprecipitated using an antibody against IKKg. All subunits of the IKK complex were immunoprecipitated in this
procedure due to IKKcomplex stability. The immunoprecipitated proteins (IKKg-IP, left side) andthe corresponding lysates (lysate, right side) were analyzed by western
blotting using antibodies against c-FLIP, IKKb and RIP. IKKb served as a loading control. (C) 0.5 10
5 293T cells were co-transfected with MEKK1, p43-FLIP and
c-FLIPL, and the luciferase reporter plasmid. NF-kB–luciferase activity was determined at 16h after transfection. The results represent the mean±s.d. values of
quadruplet cultures. GFP transfection was performed to control 100% transfection efﬁciency. (D)1 10
5 HeLa-CD95 cells were transfected with a NF-kB-dependent
luciferase reporter plasmid (1mg per well) and a Renilla reporter plasmid (100ng per well). Cells were either untreated (control), co-transfected with p43-FLIP (2mg per
well) or stimulated with TNF (500ng/ml). NF-kB–luciferase activity was determined at 16h after transfection. Renilla transfection was performed to normalize the
transfection efﬁciency. (E)1 10
5 HeLa-CD95 cells were co-transfected with a luciferase (1mg per well) and a Renilla reporter plasmid (100ng per well), as well as
pcDNA3asacontrolplasmid(control),WTc-FLIPLorc-FLIPL(D376E;2mgperwell).At24haftertransfection,cellswereleftuntreatedorwerestimulatedwith1000ng/
ml of anti-CD95. To prevent apoptosis cells were pretreated with 20mM zVAD-fmk at 30min before CD95 stimulation. NF-kB–luciferase activity was determined at 16h
after CD95 stimulation. Renilla transfection was performed to normalize the transfection efﬁciency.
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& 2010 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2010 7Figure 5 Reduced model is sufﬁcient to explain dynamics of life/death signaling. (A) Reduced model of CD95-mediated caspase and NF-kB activation. CD95 receptor and
FADD are merged into one entity named RF. (B) The table lists the consecutive reduction steps performed from models 1 to 8. (C) Model comparison using the relative
goodnessofﬁt,in which thew
2measureofmodel1issetto100%.Red diamondsindicate the number of reactionsof each modeland squares showthe corresponding number
of parameters. (D) Simulated concentrations of proteins in HeLa-CD95 cells based on the reduced model after receptor stimulation. Black, blue and red colors correspond
to 1500, 500 and 250ng/ml anti-CD95, respectively, used to induce the cells at time t¼0. C8 (sum) is observable, which sumsallconcentrations of proteins containing one copy
of procaspase-8, for example, L RF C8 FS. Squares, diamonds and triangles indicate experimental data obtained by western blot (cf. Figure 2).
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reactions decreased from 92 in the complete to 23 in the
reduced model (Figure 5C). For parameter estimation, the
search space of the optimization method was reduced by 17
dimensions because of the lowernumberof unknown reaction
constants and concentrations. Thus, the reduced model yields
a much higher conﬁdence in the parameter estimates and is
more suitable for computer-based predictions (Supplementary
Figure S6). Throughout the remainder of this study, we used
the reduced model 8 for prediction and comparison to
experimental results.
Life/death threshold concentration is independent
of the amount of CD95
Previous study on CD95-induced apoptosis demonstrated the
existence of an apoptotic threshold (Bentele et al, 2004). To
test whether our model is consistent with this ﬁnding, we
analyzed the model for such a threshold behavior using a
simulated dose–response experiment. We varied the amount
of anti-CD95 antibodies and recorded the maximum level of
active caspase-8 and NF-kB as readouts for apoptotic and NF-
kB signaling, respectively, (Figure 6A). The model predicts a
threshold of approximately 100ng/ml required to trigger the
apoptotic pathway. Tovalidate this prediction, we performed a
titration study by measuring cell death by ﬂow cytometry and
found the threshold to be in the range of 30–100ng/ml
(Figure 6B).
Next, we sought to determine how the amount of CD95
inﬂuences signal transduction of the two pathways in our cell
lines. We compared CD95-overexpressing HeLa cells with WT
HeLa cells. The endogenous amount of CD95 was estimated to
be approximately 12 times less than GFP-tagged CD95
(Figure 6C). We repeated the simulated dose–response
experiment with a decreased number of CD95 receptors. This
gave rise to two predictions: we expected a greatly reduced
activity of both pathways and, more interestingly, that the
same amount of anti-CD95 (B100ng/ml) would be sufﬁcient
to trigger apoptosis despite the lower death rate (Figure 6A).
Experimentally, we conﬁrmed that the apoptotic threshold of
HeLa WT cells was identical to that of HeLa-CD95 cells
(between 30 and 100ng/ml). However, HeLa-CD95 cells
exhibited signiﬁcantly higher rates of apoptosis (Figure 6B).
Moreover, we observe a much higher level of caspase-8
cleavage and IkBa degradation by western blot analysis in
HeLa-CD95 cells stimulated with 500ng/ml anti-CD95
(Figure 6D) than in WT HeLa cells. In summary, the increased
receptor number in HeLa-CD95 cells resulted in the ampliﬁca-
tion of both CD95-mediated apoptosis and NF-kB signaling.
Furthermore, we observed that the amount of CD95 receptors
determines the death rate, in contrast to the apoptotic
threshold concentration that remained constant.
Anti-CD95
AC
D
B
l
l
Figure 6 Life/death threshold concentration is independent of the amount of CD95. (A) The simulated dose–response curves display active NF-kB and caspase-8 as
a function of the simulation strength for HeLa cells (light gray) and HeLa-CD95 cells (dark gray). The highest concentrations attained by NF-kB* and C8* in a simulation
of 60h for a given stimulus are shown. Concentrations were scaled to unity for comparison. Vertical dotted black lines indicate the used experimental concentrations of
anti-CD95 antibody (1500/500/250ng/ml; cf. Figure 1). (B) HeLa-CD95 and WT HeLa cells were stimulated with various amounts of anti-CD95 antibodies for 18h. Cell
death was determined by ﬂow cytometry. (C) Western blot analysis of CD95 expression in HeLa-CD95 cells. GFP-tagged CD95 and endogenous CD95 are indicated.
Glycosylation of CD95 gave rise to multiple bands in the range of 42–52kDa for endogenous CD95 and 59–69kDa for GFP-tagged CD95. (D) HeLa and HeLa-CD95
cells were stimulated using 500ng/ml of anti-CD95 antibodies for the indicated time intervals. Total cellular lysates were analyzed by western blotting using antibodies
against caspase-8, IkBa and tubulin (loading control).
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differential dynamics of the two pathways
The quantiﬁed western blots of the apoptotic and NF-kB
pathways revealed an interesting feature of differential
dynamics (Figure 2). The peak of phosphorylated IkBa was
reached within 1h and was rather invariant to the stimulus
intensity (Figure 2F). On the contrary, the dynamics of
caspase-8 and caspase-3 activation showed a marked delay
with decreasing stimulus strength (Figure 2B, D and G). The
initial hypothesis was that the feedback loop in the apoptotic
pathwaybetweencaspase-8,-3and-6isthecauseforagradual
build-up of active caspases, timing of which is strongly
dependent on the stimulus concentration. Alternatively, the
differential dynamics might reﬂect an inherent feature of the
DISC formation process, in which different reaction constants
create a kinetic asymmetry for the signaling of the apoptotic
and NF-kB pathways. To discriminate between these two
hypotheses,weanalyzedthereactionspeedsofDISCassembly
in our model. The result of parameter estimation that
procaspase-8 had a lower afﬁnity for the DISC than c-FLIPL
is consistent with previous studies (Chang et al, 2002; Lavrik
et al, 2007). Model simulations demonstrated that this leads to
qualitatively different dynamics of p43/p41 and p43-FLIP
generation:withincreasingstimulusstrength,p43/p41peaked
earlier,whereastherewasalmostnodifferencewhenp43-FLIP
reached its maximum (Figure 7A and B). To validate these
predictions, we analyzed c-FLIPL cleavage by western blotting
and conﬁrmed that while the amplitude of p43-FLIP genera-
tion varied between stimulations with 1500 and 500ng/ml
antibody, the timing of the curves was identical (Figure 7C).
The predicted dynamics of p43-FLIP were matched well by the
quantiﬁed blots despite a slight disagreement at the latest time
point, in which a decrease was observed experimentally
(Figure7B).Thequalitativedifferenceoftimingofprocaspase-
8 and c-FLIPLcleavage becomes evident in Figure 7D, inwhich
we examined when p43/p41 and p43-FLIP arrived at their
maximal values as a function of stimulus strength. With
decreasing stimulus strength, p43/p41 reaches its peak level
increasingly late, whereas p43-FLIPattains themaximumlevel
earlier. Further model analysisrevealed that thiswasthe cause
of the different timing of caspase-3 and NF-kB activation
observed experimentally (Figure 2D and F). To conﬁrm that
the apoptotic feedback loop is not the reason for the
differential dynamics, we simulated the model after disrupting
the loop by removing the activation of procaspase-8 by
caspase-3. We observed that the disruption inﬂuenced p43/
p41 processing only weakly and mainly with respect to its
amplitude (Figure 7A, B and D; dashed line). This argues
againstourinitialhypothesisthatthefeedbackloopcausedthe
delayed caspase-3 activation at low doses of anti-CD95.
Instead, these results show that a kinetic asymmetry in the
process of DISC assembly was likely the reason for the
differential dynamics of apoptotic and NF-kB signaling.
The generation of p43/p41 is a hallmark of caspase
activation and apoptosis, whereas p43-FLIP engages in NF-
kB signaling in our model. Hence, we consider these proteins
as end points of signal processing at the DISC. They are the
result of the dynamic process of DISC assembly, which is
mainly determined by the levels of c-FLIP and procaspase-8.
To understand the role of c-FLIP isoforms in determining the
balance between apoptotic and NF-kB signaling, we altered
their concentrations in the simulation. We charted the
maximum levels of p43/p41 and p43-FLIP as a function of
the initial concentration of c-FLIPS after a stimulus corre-
sponding to 1000ng/ml anti-CD95 antibody (Figure 7E). As
expected from the model structure, c-FLIPS inhibited both
pathways, although p43-FLIP generation was inhibited at a
lower threshold than p43/p41 generation. We repeated the
virtual experiment with c-FLIPL with a different result
(Figure 7F). Low and high levels of c-FLIPL both inhibited
p43-FLIP generation, giving rise to a bell-shaped activation
proﬁle. This could readily be explained by the fact that cells
expressing signiﬁcantly more c-FLIPL than procaspase-8
would predominantly feature c-FLIPL trimers at the DISC,
effectively blocking downstream signaling. The vertical dotted
line in Figure 7F indicates the estimated level of c-FLIPL in our
cell line. Our model predicts that increasing the concentration
of c-FLIPL by one order of magnitude would lead to a steep
increase in p43-FLIP generation until it reaches a maximum,
beyond which the curve drops. To test this prediction, we
generated HeLa cells stably co-overexpressing CD95 and
c-FLIPL. Four clones that exhibited different levels of c-FLIPL
were selected. The CD95/c-FLIPL-overexpressing cells were
induced with 1000ng/ml of anti-CD95 antibody and analyzed
by western blotting (Figure 7G). A quantiﬁcation of c-FLIPL
before stimulation and p43-FLIP after 30min of stimulation is
showninFigure7H.The measured activationproﬁleisingood
agreement with the predicted curve of p43-FLIP generation in
Figure 7F. Cell line C exhibited the lowest level of c-FLIPL
overexpression and correspondingly less p43-FLIP generation.
With increasing levels of c-FLIPL we also found an increase in
p43-FLIP.Themodelpredictedthatatveryhighconcentrations
no p43-FLIP is generated. This drop-off was not found
experimentally, as our cell lines probably do not overexpress
c-FLIPL at sufﬁciently high levels. As the processing of
caspase-8 and c-FLIP can be different in the cytosolic pool as
compared to processing at the CD95 DISC, we performed a
CD95-IP after stably reducing the amount of c-FLIP by RNA
interference (Figure 7I). We observed that lowering the
amount of c-FLIP leads to less p43-FLIP generation at the
DISC and marginally decreased levels of p43/p41. These two
observations conﬁrm our model prediction in which lowered
levels of c-FLIPL result in very little p43-FLIP but almost
unchanged levels of p43/p41 (Figure 7F), further validating
our model of signal processing at the CD95 DISC. Thus, the
analysis of the kinetic model elucidated the complex signal
processing of c-FLIPL and procaspase-8 to p43-FLIP and p43/
p41, respectively, and explained how this leads to differential
dynamics of caspase-3 and NF-kB activation.
DISC protein stoichiometry is determinant
of cell fate
To better understand the nonlinear interplay of DISC proteins in
the determination of cell fate, we analyzed the activity of
caspase-3 and NF-kB as a function of procaspase-8 and c-FLIPL
levels (Figure 8A).We found in oursimulations that the decision
ofapoptosisandNF-kB activation is controlledby both proteins.
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Figure 7 c-FLIPL recruitment kinetics explains the differential dynamics of the two pathways. (A) Simulation and experimental data of p43/p41 dynamics for 1500 and
500ng/ml of stimulating anti-CD95 antibody. (B) Same as (A) for p43-FLIP. The data points were obtained by quantifying the blots shown in (C). (C) HeLa-CD95 cells
stimulated with 1500/500ng/ml anti-CD95 for the indicated time points. Lysates were used for western blots analysis using an antibody against c-FLIP. The full-length
formofc-FLIPLanditscleavageproductp43-FLIPareindicated.(D)Thecurvesshowthetimewhenp43/p41andp43-FLIPreachedtheirpeaklevelinthesimulationas
a function of the antibody concentration. (E) Model prediction of the maximal concentration of p43/p41 and p43-FLIP depending on the initial concentration of c-FLIPS.
The dotted line indicates the estimated level of c-FLIPS in our setting. Stimulation intensity corresponds to 1000ng/ml of anti-CD95 antibodies. (F) Same as in (E) but
withc-FLIPL.(G)WesternblottingoffourdifferentclonesofHeLa-CD95cellsstablyoverexpressingc-FLIPLindifferentamounts.Westernblotsshowthefull-lengthform
of c-FLIPL and its cleavage product p43-FLIP after induction with 1000ng/ml of anti-CD95 for the indicated time points. Tubulin serves as a loading control.
(H)Quantiﬁcation of(G)byplottingthe intensity ofc-FLIPL at0min againstp43-FLIPat 30min.Fornormalization, theamounts ofc-FLIPL andp43-FLIP inclone C were
set to 1, as they exhibited the lowest levels. (I) HeLa-CD95 cells with a stable c-FLIP downregulation (c-FLIP ) and control-transfected HeLa-CD95 cells (c-FLIPþ)
were generated by RNA interference. The cells were kept under nonstimulated conditions for control (anti-CD95 ) or stimulated with 500ng/ml anti-CD95 for 30min
(anti-CD95þ). The CD95-IP was performed using anti-CD95 antibodies. The immunoprecipitated proteins (CD95-IP) and the lysates were analyzed by western blot
usingantibodies againstcaspase-8,c-FLIPandCD95. Secondary antibodiesrecognize theheavy chain(50kDa)oftheantibody usedfor theIPs.Thus,theheavy chain
of the antibody used for immunoprecipitation is marked in the western blot with an asteric (*¼IgGH). Importantly, the amount of antibody in the unstimulated lane was
always higher as it was added after cell lysis.
DISC dynamics decide life and death of cells
L Neumann et al
& 2010 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2010 11C
A
C
E
D
B
l ll
Figure 8 DISC protein stoichiometry is determinant of cell fate. (A) This model-based prediction illustrates how different levels of procaspase-8 and c-FLIPL may lead
to different phenotypes. The logarithm of the maximum concentration of active NF-kB (green) and caspase-3 (red) in a simulation of 6h after CD95 stimulation is shown
as a function of the initial concentration of procaspase-8 and c-FLIPL. Dotted lines were drawn manually to delineate different regimes of activation. The blue circle
indicates the estimated level of c-FLIPL and procaspase-8 in HeLa-CD95 cells. (B) Sensitivity analysis. Absolute values of relative sensitivities were averaged over a
time interval of 360min. The pie chart shows the contribution of different parameter categories to the total sensitivity. For variable and parameter numbers see
Supplementary Tables S1and S2. (C)HeLa-CD95 cells stably downregulating procaspase-8 were generated by RNA interference andcompared against controlHeLa-
CD95 cells. Both cell lines were stimulated with 500ng/ml anti-CD95 for the indicated time intervals. The lysates were used for western blot analysis against caspase-8,
p-IkBa,c-FLIP and tubulin. (D) Cell death assay of HeLa-CD95 cellswithc-FLIPL overexpression. Speciﬁc apoptosis normalized to 100% for HeLa-CD95 cells (control)
is shown. Cells were treated with the depicted amount of anti-CD95 for 18h. Cell death was determined with PI staining and analyzed with ﬂow cytometry. Speciﬁc cell
death was calculated as described in Materials and methods section. (E) c-FLIP-deﬁcient HeLa-CD95 cells were transiently transfected with WT c-FLIPL (middle) or
c-FLIPL (D376E; right; 15ng per well). At 24h after transfection, cells were stimulated with 1000ng/ml anti-CD95 for the indicated time intervals. The lysates were used
for western blot analysis against p-IkBa, c-FLIP, caspase-8, caspase-3, PARP and tubulin.
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absence of either caspase-3 activity or NF-kB activity. The
estimated levels of procaspase-8 and c-FLIPL in HeLa-CD95
cells are located in the central area of the phase-like diagram.
Small changes in concentration can trigger different scenarios,
helping to reconcile earlier conﬂicting observations (Kataoka
et al, 2000; Chang et al, 2002; Micheau et al, 2002; Budd et al,
2006) regarding the role of c-FLIPL in cell-fate decision. Our
model predicts that c-FLIPL disables, promotes and inhibits
NF-kBactivation,respectively,dependingonwhetherthelevel
of c-FLIPL is low, in an intermediary range or high,
respectively. To further corroborate the importance of DISC
protein levels we performed a sensitivity analysis (Figure 8B).
The initial concentrations of DISC proteins—especially of
c-FLIP isoforms—were found to be the most sensitive
parameters, summing up to 63% of the total sensitivities.
The remaining 20 parameters contributed only to 37% of total
sensitivities. This result explains how relatively small changes
in the abundance of DISC proteins might lead to drastic
changes in downstream signaling as already observed for the
amount of CD95 (Figure 6).
To determine the role of procaspase-8 concentration, we
downregulated procaspase-8 in HeLa-CD95 cells using RNA
interference (Figure 8C). The decrease in procaspase-8 level
resultedinasigniﬁcantlyloweramountofp43-FLIPafterCD95
stimulation. Subsequently, it led to the abolishment of CD95-
mediated phosphorylation of IkB. Furthermore, the amount of
active caspase-8, p18, was decreased, hence leading to
reduced apoptosis. Therefore, by perturbing the ratio of
procaspase-8 to c-FLIPL at the DISC, we have inﬂuenced the
induction of apoptosis and NF-kB activation. The phase
diagram shown in Figure 8A predicts that either increasing
or decreasing the amount of c-FLIPL leads to a different
signaling mode. To test this prediction, we modulated c-FLIPL
in HeLa-CD95 cells and measured cell death. Figure 8D
displays speciﬁc apoptosis of Hela-CD95 cells after CD95
stimulation at various concentrations around the threshold
determined in Figure 6. In agreement with the phase diagram
(Figure 8A), we observed that c-FLIPL overexpression resulted
in a strong reduction of apoptosis. The downregulation of
c-FLIPL, on the contrary, did not lead to a signiﬁcant change of
the death rate(Supplementary FigureS7). Thus,high amounts
of c-FLIPL affect the level of programmed cell death after CD95
stimulation. Moreover, we could further conﬁrm by western
blot analysis that downregulation of c-FLIP led to a reduction
of the levels of p43-FLIP and phosphorylated IkBa after CD95
stimulation (Supplementary Figure S8A). We wanted to rule
out the possibility that the reduced amount of phosphorylated
IkBa is because of increased caspase activity upon c-FLIPL
downregulation, which could potentially block activation of
NF-kB.Therefore,weperformedtheanalysisinthepresenceof
zVAD-fmk (Supplementary Figure S8B). The results were
similar: stable downregulation of c-FLIPL led to a reduction of
IkBa phosphorylation after CD95 stimulation. In addition, to
control the speciﬁcity of c-FLIP downregulation and further
conﬁrmthe requirementof cleavage of c-FLIPL to p43-FLIP, we
performed a reconstitution experiment in HeLa-CD95–c-FLIP-
deﬁcient cells (Figure 8E). Cells reconstituted with WTc-FLIPL
were able to generate p43-FLIP and increased IkBa phospho-
rylation upon CD95 stimulation. Incontrast, cells reconstituted
with the noncleavable mutant of c-FLIPL (D376E) did not show
processing to p43-FLIP (Figure 8E; Supplementary Figure S9).
Noticeably, as postulated by the model, this resulted in a strong
reduction of the levels of IkBa phosphorylation upon CD95
stimulation. We also demonstrated that this effect does not
result from a change of caspase activity of HeLa-CD95 cells
reconstituted with c-FLIPL (D376E), as the extent of caspase-3
activation and PARP cleavage was comparable with that in
c-FLIP-deﬁcient cells (Figure 8E). Taken together, these data
conﬁrm our model postulates that cleavage of c-FLIPL to p43-
FLIP is required for CD95-mediated NF-kB activation and that
the DISC protein levels determine cell fate in a nonlinear
manner, highlighting the role of signal processing within
the DISC.
Discussion
In this study, we propose an integrated kinetic model of CD95-
mediated apoptosis and NF-kB signaling. This was achieved
by integrating mechanistic knowledge of DISC assembly and
caspase activation with a simple scheme of NF-kB activation.
The details of DISC formation have been mostly disregarded in
earlier modeling studies of CD95 signaling. Typically, the only
function of the DISC was to convert signals from CD95L into
active caspase-8. If included, c-FLIP was assigned only an
inhibitory function and p43-FLIP generation was neglected
(Fussenegger et al, 2000; Bentele et al, 2004; Hua et al, 2005).
As a recent study has indicated that the speciﬁc conﬁguration
of proteins at the CD95 DISC activates distinct signaling
pathways (Budd et al, 2006), we built a mechanistic model
with a high level of detail at the DISC and performed a
systematic model reduction. The resulting model is simple yet
fully compatible with the current paradigm of CD95 signaling.
A large part of its components were observed experimentally,
which increased the reliability of the parameter estimates.
Furthermore, it could reproduce the experimentally observed
dynamics and proved to be a powerful predictive tool.
The large amount of CD95 sensitizes HeLa-CD95 cells for
caspase and NF-kB activation and renders them a valuable
tool for the study of p43/p41 and p43-FLIP generation at the
DISC. We used live-cell imaging to show that CD95 induces
apoptosis in HeLa-CD95 cells and that it is accompanied by
translocation of NF-kB to the nucleus. However, we did not
observe oscillatory dynamics as published by others (Nelson
et al, 2004), which is likely to be a cell type-dependent
phenomenon.
We provide new evidence for a direct link between CD95
stimulation and NF-kB activation. According to our study,
c-FLIPL is cleaved to p43-FLIP, which interacts with the IKK
complex leading to its activation. This pathway differs from
p22-FLIP-mediated NF-kB activation, in which procaspase-8
cleavesc-FLIPLtop22-FLIPindependentlyofCD95stimulation
(Golks et al, 2006a). We did not observe p22-FLIP formation in
HeLa-CD95 cells on CD95 stimulation (data not shown). The
RIP protein, another mediator of DR-induced NF-kB activation
(Kataoka and Tschopp, 2004; Kreuzet al, 2004; Dohrman et al,
2005; Misraet al,2005),wasnotdetectedtobe associatedwith
the IKK complex, which does not rule out that it is involved in
the NF-kB pathway studied here.
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clones lacking IKKg, FADD or caspase-8 abolished CD95-
mediated upregulation of the NF-kB target gene IkBa (Kreuz
et al, 2004). They also found that CD95-mediated NF-kB
activity relies on a full-length procaspase-8 rather than on the
processed form and upregulation of c-FLIPL and that c-FLIPS
inhibits CD95-mediated NF-kB activity. Furthermore, c-FLIP-
deﬁcient Tcellsdisplayed diminished proliferation(Zhang and
He, 2005). Furthermore, overexpression of c-FLIPL in Jurkat
cells increased NF-kB activity upon TCR stimulation (Zhang
and He, 2005), whereas downregulation of c-FLIPL was shown
to either increase (Kreuz et al, 2004) or not inﬂuence CD95-
induced NF-kB activity (Legembre et al, 2004). As suggested
by our model analysis, these conﬂicting data might be
explained by different levels of c-FLIP proteins in the different
investigated cell systems. Data from c-FLIPL transgenic mice
strongly support the role of c-FLIPL in proliferative pathways
(Lens et al, 2002; Dohrman et al, 2005). We have found that
c-FLIPL levels crucially determine the balance between
apoptotic and NF-kB signaling by shaping the dynamics of
DISC assembly. Although this ﬁnding is based on experiments
performed in cell lines with limited physiological importance,
we expect that the nonlinear dynamics of DISC assembly is a
generic systems property of life/death decision making in
CD95 signaling pathways. This is especially important for
physiologically relevant cells, such as various cancer cells that
are resistant towards death receptor-induced apoptosis. This
hypothesis, however, needs careful experimental validation
and will be subject to further investigation in our lab.
Our results support the emerging paradigm in CD95
signaling that the DISC can act as a potent signal processor
deciding between life and death (Lavrik et al, 2007). Why then
would the same receptor trigger two pathways with opposing
phenotypes? Nuclear factor-kB is a transcription factor for the
c-FLIP and the IAP family (Krammer et al, 2007). Hence,
upregulation of these apoptosis inhibitors may maintain a
threshold toward CD95-mediated apoptosis, thereby prevent-
ing unwanted apoptotic effects at low amounts of CD95L. In
our modeling approach, we concentrated on early signaling
events, which took place within a few hours after CD95
stimulation. We neglected gene expression induced by NF-kB
as we did not observe upregulation of the c-FLIP isoforms at
theproteinlevelwithin theinitialhours. Itremainsachallenge
for future study to integrate a model of CD95-mediated signal
transduction with a model of transcriptional regulation to
capture the possible feedback from transcriptional regulation
by NF-kB onto upstream CD95 signaling.
Materials and methods
Cell lines
HeLa-CD95wasgeneratedbyselectionwithG418,HeLa-CD95–c-FLIPL
and HeLa-CD95–p65–mCherry by selection with G418 and puromycin
(Sigma-Aldrich) according to standard protocols. HeLa, HeLa-CD95
and HeLa-CD95–c-FLIPL cells were maintained in DMEM (Life
Technologies, Germany), 10mM HEPES (Life Technologies), 50mg/ml
gentamycin (Life Technologies), 10% fetal calf serum (Life Technolo-
gies) in 5% CO2. G418 (0.5mg/ml) was used to maintain HeLa-CD95
cells and a mix of G418 (0.25mg/ml) and puromycin (0.2mg/ml) was
used to maintain HeLa-CD95–c-FLIPL and HeLa-CD95–p65–mCherry.
Transfections were done using FuGene 6 (Roche, Switzerland).
DNA constructs
The CD95–GFP fusion was made by fusing the entire coding sequence
of CD95 50 to mGFP (Snapp et al, 2003) with the linker TRDPPVAT in
between. To generate cells stably expressing c-FLIPL, the coding
sequence of c-FLIPL was cloned in the pIRESpuro2 vector (Clontech).
p65–mCherry and pSilencer 3.1-H1 Neo vector were kindly provided
by Dr Nathan Brady. The FLAG-IKKg plasmid was a kind gift from Dr
Ralf Marienfeld, FLAG-IKKa and -b plasmids were kind gifts from
Professor Hiroyasu Nakano; MEKK1 plasmid was a kind gift from
Professor Peter Angel and the luciferase reporter construct was
provided by Dr Ru ¨diger Arnold (Arnold et al, 2001). The vector for
c-FLIP downregulation was provided by Professor Martin Leverkus
(Diessenbacher et al, 2008).
Cloning of c-FLIPL and c-FLIPL mutants
c-FLIP was cloned into the pcDNA3 expression vector (Invitrogen)
using the KpnI and ApaI restriction sites. Several mutants were
obtained through overlapping PCR. The mutated nucleotides are
indicated in bold. The following primers were used:
c-FLIPL_for: 50-Q4CGGGGTACCATGTCTGCTGAAGTCATCC-30
c-FLIPL_rev: 50-GCCGGCCCTTATGTGTAGGAGAGGATAAG-30
D196E_for: 50-GTCTCAAGGAGCCTTCAAATAACTTCAGGCTCC-30
D196E_rev: 50-GAAGGCTCCTTGAGACTCTTTTGGATTGCTGC-30
p43_rev: 50-GCGGCCCCAATCCACCTCCAAGAGGCTGC-30
c-FLIP-reconstitution_for: 50-GGCGCTGGCACTAGGTATAGGAATGT
TCTCCAAGCAG-30
c-FLIP-reconstitution_rev: 50-ATACCTAGTGCCAGCGCCTTGAACAG
ACTGCTTGTAC-30
Antibodies and reagents
Anti-FADD mAb (IgG1) was purchased from Transduction Labora-
tories (Lexington, KY). Anti-IkBa, anti-phospho-IkBa, anti-IKKa/b/g,
anti-CD95 C20 polyclonal antibodies and anti-RIP monoclonal
antibody were purchased from Santa Cruz Biotechnology (USA).
Anti-caspase-8 monoclonal antibody C15 (mouse IgG2b) recognizes
the p18 subunit of caspase-8 (Scafﬁdi et al, 1997). Anti-FLIP
monoclonal antibody NF6 (mouse IgG1) recognizes the N-terminal
part of c-FLIP (Scafﬁdi et al, 1999). Anti-FLAG monoclonal anti-
body M2 (mouse IgG1) was purchased from Sigma (Deisenhofen,
Germany). As anti-CD95 antibody we always used anti-APO-1
antibody. Anti-APO-1 antibody is an agonistic monoclonal anti-
body (IgG3) recognizing an epitope on the extracellular part of
CD95 (APO-1/Fas; Trauth et al, 1989). LZ-CD95L was prepared as
described before (Walczak et al, 1999). Horseradish peroxidase-
conjugated goat anti-mouse IgG1, -2a and -2b were purchased
from Southern Biotechnology Associates (Echingen, Germany). All
chemicals used were of analytical grade and purchased from Merck
(Darmstadt, Germany) or Sigma. Renilla (pGL4.74) vector was from
Promega (Mannheim, Germany).
Analysis of total cellular lysates
A total of 10
7 cells were either treated with indicated amounts of anti-
CD95 antibody for indicated periods of time at 371C or left untreated,
washed twice in 1  PBS and lysed subsequently in lysis buffer A
(30mM Tris–HCl (pH 7.5), 150mM NaCl, 2mM EDTA, 1mM
phenylmethylsulfonyl ﬂuoride (Sigma, Germany), protease inhibitor
cocktail, 1% Triton X-100 (Serva, Germany) and 10% glycerol). If pre-
treated with zVAD-fmk, cells were pre-incubated for 30min at 371C
with the indicated concentrations of zVAD-fmk before stimulation.
Total cellular lysates were analyzed using SDS–PAGE gels. Proteins
were transferred to Hybond nitrocellulose membrane (Amersham
Pharmacia Biotech, Germany), blocked with 5% non-fat dry milk in
PBS/Tween (PBS plus 0.05% Tween 20) for 1h, washed with PBS/
Tween and incubated with the primary antibody in PBS/Tween
overnight at 41C. Blots were developed with a chemoluminescence
method according to the manufacturer’s protocol (Perkin Elmer Life
Sciences, Germany).
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Cells were cultured in 8-well Lab-Tek chambered cover glasses (Nunc,
Germany). During imaging, cells were maintained at 371C in DMEM
without phenol red and complemented with 20mM HEPES buffer and
10% FCS. We used a Leica SP2 laser scanning confocal microscope
(Leica Microsystems, Germany) with a  63 oil immersion lens. For
excitation, the laser wavelength was set to 488nm for GFPand 594nm
for mCherry. The recording spectrum was 498–535nm for GFP and
604–686nm for mCherry.
IKKc IP
A total 1.2 10
6 HeLa-CD95 cells were lysed in lysis buffer A (with or
without stimulation, divided into two equal parts and the IP was
performed by using 2mg anti-IKKg antibody or isotype control
antibodies together with 30ml of protein-A–Sepharose. Immunopreci-
pitations were performed overnight at 41C; then beads were washed
ﬁvetimeswith20volumesoflysisbufferandsubjectedtowestern blot
analysis as described above.
CD95 DISC IP
A total of 1 10
7 HeLa-CD95 cells were lysed in lysis buffer A, with or
without stimulation, divided into two equal parts and the DISC IP was
performed by using 5mg anti-CD95 (anti-APO-1) antibody together
with 30ml of protein A–Sepharose. Immunoprecipitations were
performed overnight at 41C; then beads were washed ﬁve times with
20 volumes of lysis buffer and subjected to western blot analysis as
described above.
NF6 and FLAG IPs
A total of 2 10
6 293T cells were transfected using the calcium
phosphate method 1 day before lysis. Then cells were lysed in a
volume of 1ml for 30min at 01C. The FLIP IP was performed using
100 ml of NF6 hybridoma supernatant together with 30ml of protein A–
Sepharose. The FLAG IP was performed by using 4mg anti-FLAG mAb
together with 30ml of protein A–Sepharose. Immunoprecipitations
were performed for 1h at RT or overnight at 41C, then beads were
washed ﬁve times with 20 volumes of lysis buffer and subjected to
western blot analysis as described above.
Stable siRNA expression
We used stable expression of siRNA as published previously
(Diessenbacher et al, 2008). The siRNA FLIP vector or control empty
vector were transfected into the HeLa-CD95 cell line as described
earlier (Diessenbacher et al, 2008). The downregulation of caspase-8
was done with a pSilencer 3.1-H1 Neo vector. The siRNA target
sequence was 50-gggtcatgctctatcagat-30 as desribed by Wagner et al
(2004). c-FLIPL-deﬁcient cells were reconstituted with c-FLIPL-
mutants using Lipofectamine transfection reagent according to the
manufacturer’s protocol. Silent mutations were introduced in WT
c-FLIPL and c-FLIPL (D376E) to avoid silencing by siRNA (refer to
cloning of c-FLIPL and c-FLIPL mutants). Only 15ng DNA per well of a
6-well plate were transfected to obtain an approximately physiological
level of c-FLIPL.
Quantiﬁcation of western blot time series
The western blots were scanned and analyzed using ImageJ (http://
rsb.info.nih.gov/ij/). The local background from bands was sub-
tracted and their intensity was quantiﬁed. For normalization, the
signal was divided by the anti-tubulin signal. For alignment of time,
series from repeated experiments the signals were multiplied with a
scalar to minimize the sum of mean-squared distances of measure-
ments at the same time points. Finally, the average signal was
computed and scaled.
NF-jB activation assay
The 24-well titer plates were seeded with 0.5 10
5 293Tcells the day
before transfection. Cells were transfected using the calcium phos-
phate method with various expression vectors, together with the
NF-kB-driven luciferase reporter plasmid (500ng) and a Renilla
plasmid for normalization (100ng). Cells were washed with PBS at
16h after transfection and lysed for 20min at RT in 50ml lysis buffer
(Passive lysis buffer, Promega) followed by centrifugation (10000 g,
20min)tosedimentinsolublematerials.Avolumeof5mlofcelllysates
were mixed with 50ml of the luciferase assay mixture (470mM Beetle
Luciferin (Promega), 1.07mM (MgCO3)4Mg(OH)2 5H 2O, 20mM
N-Tris-(hydroxymethyl)-methylglycine, 2.67mM MgSO4,1 0 0 mM
EDTA, 33.3mM DTT, 270mM CoA(OAc), 530mM ATP). Relative light
units were measured with a Berthold duoluminomat (Bad Wildbad,
Germany). For the assays in HeLa-CD95 cells, 6-well titer plates were
seeded with 0.5 10
5 HeLa-CD95 cells the day before transfection.
Cells were transfected using Fugene with various expression vectors,
together with the NF-kB-driven luciferase reporter plasmid (2mg;
Arnold et al, 2001) and Renilla luciferase plasmid (100ng) used as
normalization control. Subsequently, measurements were performed
similar to those for 293Tcells.
Cell death assay
Cellswereplatedandtreatedasindicatedwithanti-APO-1antibodyfor
18h and 1mg/ml propidium iodide for 30min. Cell death was assessed
by propidium iodide uptake and quantiﬁed using a Cytomics FC 500
MPL ﬂow cytometer (Beckman Coulter). Speciﬁc cell death was
calculated as follows: (percentage of experimental cell death percen-
tage of spontaneous cell death)/(100 percentage of spontaneous cell
death) 100 and calibrated to 100% for the peak value.
Modeling and simulation
The molecular interactions depicted in Figure 3 were noted down as
uni- or bimolecular reactions and subsequently translated into a
system of coupled ordinary differential equations according to the law
of mass action (Supplementary Table S1). The reduced model is
available in SBML format as Supplementary information. We used the
software MATLAB (MathWorks, USA) and SBtoolbox (http://
www.sbtoolbox.org) for modeling, simulation and analysis.Unknown
reaction constants, initial concentrations and data scaling parameters
were estimated by maximizing the maximum likelihood criterion with
MATLAB’s lsqnonlin function (Supplementary Table S2; for details see
Bentele et al (2004)). For every model, the estimation was repeated
several thousand times from different, randomly chosen starting
points to avoid convergence to local minima. Model ﬁts were
compared using the w
2 measure of goodness of ﬁt. The normalized
ﬁt was obtained by dividing the w
2 value of the complete model by the
w
2valueofthereducedmodelandsubsequentmultiplicationby100%.
Sensitivity analysis
The relativesensitivityof avariable xi at time t (in min) with respect to
a parameter pj is given by
sijðtÞ¼ð pj=xiÞ ð dxi=dpjÞ:
Time-averaged sensitivities were computed according to
Sij ¼ð 1=361Þ
X
t¼0;1;...;360
jsijðtÞj:
We summed absolute values to rule out that positive and negative
sensitivities cancel each other. For the pie chart, parameters were
grouped into categories as displayed. All values, Sij, belonging to the
same category were summed and subsequently compared.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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